| Primary |
| Hepatitis C |
64.9% |
| Product Used For Unknown Indication |
6.9% |
| Drug Use For Unknown Indication |
6.8% |
| Chronic Hepatitis C |
5.2% |
| Hypertension |
3.2% |
| Depression |
2.8% |
| Hepatitis B |
2.1% |
| Pain |
1.2% |
| Anxiety |
0.8% |
| Hiv Infection |
0.8% |
| Insomnia |
0.8% |
| Hepatitis |
0.7% |
| Anaemia |
0.6% |
| Hepatic Cirrhosis |
0.5% |
| Hepatitis C Virus |
0.5% |
| Hypothyroidism |
0.5% |
| Prophylaxis |
0.5% |
| Bipolar Disorder |
0.4% |
| Asthma |
0.4% |
| Diabetes Mellitus |
0.4% |
|
| White Blood Cell Count Decreased |
30.8% |
| Weight Decreased |
10.4% |
| Death |
9.7% |
| Vomiting |
7.2% |
| Thrombocytopenia |
4.9% |
| Pyrexia |
4.4% |
| Rash |
3.8% |
| Platelet Count Decreased |
3.5% |
| Syncope |
3.0% |
| Anaemia |
2.8% |
| Pneumonia |
2.4% |
| Renal Failure |
2.4% |
| Weight Increased |
2.0% |
| Vision Blurred |
2.0% |
| Nausea |
1.9% |
| Thrombosis |
1.9% |
| Sepsis |
1.8% |
| Pancytopenia |
1.8% |
| Convulsion |
1.7% |
| Suicidal Ideation |
1.7% |
|
| Secondary |
| Hepatitis C |
81.6% |
| Chronic Hepatitis C |
4.4% |
| Product Used For Unknown Indication |
4.0% |
| Hypertension |
1.6% |
| Drug Use For Unknown Indication |
1.3% |
| Depression |
1.3% |
| Hiv Infection |
0.9% |
| Pain |
0.6% |
| Anaemia |
0.5% |
| Diabetes Mellitus |
0.5% |
| Hepatitis B |
0.4% |
| Anxiety |
0.4% |
| Prophylaxis |
0.4% |
| Insomnia |
0.4% |
| Hepatic Cirrhosis |
0.3% |
| Hepatitis C Virus |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Hypothyroidism |
0.3% |
| Rash |
0.2% |
| Thrombocytopenia |
0.2% |
|
| White Blood Cell Count Decreased |
23.3% |
| Rash |
11.0% |
| Weight Decreased |
10.1% |
| Vomiting |
9.7% |
| Pruritus |
5.3% |
| Nausea |
4.9% |
| Fatigue |
4.5% |
| Pyrexia |
3.5% |
| Rash Pruritic |
3.3% |
| Weight Increased |
3.2% |
| Thrombocytopenia |
2.9% |
| Drug Ineffective |
2.9% |
| Anaemia |
2.7% |
| Platelet Count Decreased |
2.5% |
| Rash Generalised |
2.2% |
| Pain |
1.8% |
| Influenza Like Illness |
1.7% |
| Red Blood Cell Count Decreased |
1.7% |
| Headache |
1.5% |
| Vision Blurred |
1.3% |
|
| Concomitant |
| Hepatitis C |
87.9% |
| Hypertension |
2.5% |
| Product Used For Unknown Indication |
1.6% |
| Hiv Infection |
1.2% |
| Depression |
0.9% |
| Diabetes Mellitus |
0.9% |
| Pain |
0.8% |
| Chronic Hepatitis C |
0.6% |
| Anxiety |
0.6% |
| Anaemia |
0.5% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Hypothyroidism |
0.3% |
| Prophylaxis |
0.3% |
| Medical Diet |
0.3% |
| Blood Pressure |
0.3% |
| Drug Use For Unknown Indication |
0.2% |
| Schizophrenia |
0.2% |
| Pruritus |
0.2% |
| Insomnia |
0.2% |
| Sleep Disorder |
0.2% |
|
| Rash |
13.7% |
| Nausea |
8.8% |
| Vomiting |
8.8% |
| White Blood Cell Count Decreased |
8.3% |
| Fatigue |
7.4% |
| Pruritus |
6.9% |
| Anaemia |
6.3% |
| Rash Pruritic |
4.9% |
| Drug Ineffective |
4.2% |
| Weight Decreased |
4.2% |
| Rash Generalised |
4.2% |
| Pyrexia |
3.2% |
| Headache |
3.1% |
| Diarrhoea |
3.0% |
| Anorectal Discomfort |
2.9% |
| Haemorrhoids |
2.4% |
| Influenza Like Illness |
2.3% |
| Drug Dose Omission |
1.9% |
| Platelet Count Decreased |
1.9% |
| Pruritus Generalised |
1.9% |
|
| Interacting |
| Hepatitis C |
44.2% |
| Chest Pain |
9.6% |
| Chronic Hepatitis C |
8.7% |
| Hypertension |
5.8% |
| Bone Density Decreased |
4.8% |
| Depression |
4.8% |
| Nausea |
4.8% |
| Hiv Infection |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Drug Use For Unknown Indication |
1.9% |
| Hepatitis C Virus |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Anaemia |
1.0% |
| Hepatitis |
1.0% |
| Psoriatic Arthropathy |
1.0% |
| Urinary Tract Infection |
1.0% |
|
| Drug Interaction |
12.0% |
| Anxiety |
8.0% |
| Proctalgia |
8.0% |
| Proteinuria |
8.0% |
| Rash Generalised |
8.0% |
| Renal Failure Acute |
8.0% |
| Thrombocytopenia |
8.0% |
| Depression |
4.0% |
| Dialysis |
4.0% |
| Liver Function Test Abnormal |
4.0% |
| Muscular Dystrophy |
4.0% |
| Neutropenia |
4.0% |
| Pneumonia |
4.0% |
| Polyneuropathy |
4.0% |
| Psychotic Disorder |
4.0% |
| Tuberculosis |
4.0% |
| Weight Decreased |
4.0% |
|
